Status:
RECRUITING
Endoscopic Severity Image Recognition to Advance Research and Training in Inflammatory Bowel Disease (EVEREST - IBD)
Lead Sponsor:
Hull University Teaching Hospitals NHS Trust
Collaborating Sponsors:
Wellcome/EPSRC Centre for Interventional and Surgical Sciences, University College London
Conditions:
Inflammatory Bowel Disease 1
Eligibility:
All Genders
16-99 years
Brief Summary
To develop and train a convolutional neural network to detect and characterize disease severity of inflammatory bowel disease during endoscopy
Detailed Description
To develop and train a Convolutional Neural Network to detect and characterize disease severity in inflammatory bowel disease during endoscopy. This initiative will inevitably establish a high-quality...
Eligibility Criteria
Inclusion
- • Any adult patient aged 16 years or older who has consented to undergo endoscopic investigation where images are captured as part of routine clinical care.
Exclusion
- • Any patient under the age of 16
- Patients who are unable to give informed consent to undergo endoscopic investigation or those who do not wish their pseudo-anonymised images to be used
Key Trial Info
Start Date :
September 17 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2031
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT04867408
Start Date
September 17 2021
End Date
September 1 2031
Last Update
November 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hull Royal Infirmary
Hull, East Yorkshire, United Kingdom, HU3 2JZ